Pharmacology, Toxicology and Pharmaceutical Science
Hepatoblastoma
100%
Chemotherapy
50%
Cardiotoxicity
50%
First-Line Chemotherapy
50%
Epirubicin
50%
Disease
50%
Survival Rate
25%
Infection
25%
Cyclophosphamide
25%
Cisplatin
25%
Prematurity
25%
Overall Survival
25%
Chronic Hepatitis B
25%
Etoposide
25%
Event Free Survival
25%
Second-Line Chemotherapy
25%
Beckwith Wiedemann Syndrome
25%
Neoplasm
25%
Fluorouracil
25%
Carboplatin
25%
Vincristine
25%
Febrile Neutropenia
25%
Medicine and Dentistry
Hepatoblastoma
100%
Epirubicin
50%
First-Line Chemotherapy
50%
Cardiotoxicity
50%
Survival Rate
25%
Disease
25%
Neoplasm
25%
Infection
25%
Cyclophosphamide
25%
Fluorouracil
25%
Overall Survival
25%
Prematurity
25%
Vincristine
25%
Chronic Hepatitis B
25%
Carboplatin
25%
Event Free Survival
25%
Febrile Neutropenia
25%
Progressive Disease
25%
Second-Line Chemotherapy
25%
Beckwith Wiedemann Syndrome
25%
Precocity
25%
Cisplatin
25%
Etoposide
25%